Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bupivacaine alone versus bupivacaine plus intravenous dexamethasone for prolonging analgesia after supraclavicular brachial plexus block
PACTR202509579633417Completed
- Sponsor
- Orotta College of Medicine and Health Sciences
- Start
- Dec 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Trial of bupivacaine and dexamethasone in postoperative pain (2 arms), sponsored by Orotta College of Medicine and Health Sciences. Primary endpoint: Duration of postoperative analgesia. Started Dec 2024; status: completed.
02
Drugs
bupivacainedexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on PACTR202509579633417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202509579633417.